Cheng-Chang Chang

10PUBLICATIONS
21CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursDeep learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 12, 2022
A Weakly Supervised Deep Learning Method for Guiding Ovarian Cancer Treatment and Identifying an Effective Biomarker.

Ching-Wei Wang, Yu-Ching Lee, Cheng-Chang Chang

|Jan 28, 2022
Histopathological whole slide image dataset for classification of treatment effectiveness to ovarian cancer.

Ching-Wei Wang, Cheng-Chang Chang, Muhammad Adil Khalil

|Nov 03, 2021
Loss of ten-eleven translocation 1 (TET1) expression as a diagnostic and prognostic biomarker of endometrial carcinoma.

Nien-Tzu Liu, Cherng-Lih Perng, Yu-Ching Chou

|Oct 13, 2021
AIM2 Inflammasome in Tumor Cells as a Biomarker for Predicting the Treatment Response to Antiangiogenic Therapy in Epithelial Ovarian Cancer Patients.

Po-Chao Hsu, Tai-Kuang Chao, Yu-Ching Chou

|Aug 27, 2021
Synergistic AHR Binding Pathway with EMT Effects on Serous Ovarian Tumors Recognized by Multidisciplinary Integrated Analysis.

Kuo-Min Su, Hong-Wei Gao, Chia-Ming Chang

|Apr 30, 2021
Dysregulated Immunological Functionome and Dysfunctional Metabolic Pathway Recognized for the Pathogenesis of Borderline Ovarian Tumors by Integrative Polygenic Analytics.

Chia-Ming Chang, Yao-Feng Li, Hsin-Chung Lin

Pageof 2

Frequent Collaborators

4 joint publications

Li-Chun Liu

3 joint publications

Chia-Ming Chang

2 joint publications

Tai-Kuang Chao

2 joint publications

Po-Chao Hsu